Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 4
2014 2
2017 1
2018 2
2020 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance.
Bloy N, Garcia P, Laumont CM, Pitt JM, Sistigu A, Stoll G, Yamazaki T, Bonneil E, Buqué A, Humeau J, Drijfhout JW, Meurice G, Walter S, Fritsche J, Weinschenk T, Rammensee HG, Melief C, Thibault P, Perreault C, Pol J, Zitvogel L, Senovilla L, Kroemer G. Bloy N, et al. Among authors: garcia p. Immunol Rev. 2017 Nov;280(1):165-174. doi: 10.1111/imr.12582. Immunol Rev. 2017. PMID: 29027230 Review.
eIF2α phosphorylation is pathognomonic for immunogenic cell death.
Bezu L, Sauvat A, Humeau J, Gomes-da-Silva LC, Iribarren K, Forveille S, Garcia P, Zhao L, Liu P, Zitvogel L, Senovilla L, Kepp O, Kroemer G. Bezu L, et al. Among authors: garcia p. Cell Death Differ. 2018 Aug;25(8):1375-1393. doi: 10.1038/s41418-017-0044-9. Epub 2018 Jan 22. Cell Death Differ. 2018. PMID: 29358668 Free PMC article.
Cisplatin resistance associated with PARP hyperactivation.
Michels J, Vitale I, Galluzzi L, Adam J, Olaussen KA, Kepp O, Senovilla L, Talhaoui I, Guegan J, Enot DP, Talbot M, Robin A, Girard P, Oréar C, Lissa D, Sukkurwala AQ, Garcia P, Behnam-Motlagh P, Kohno K, Wu GS, Brenner C, Dessen P, Saparbaev M, Soria JC, Castedo M, Kroemer G. Michels J, et al. Among authors: garcia p. Cancer Res. 2013 Apr 1;73(7):2271-80. doi: 10.1158/0008-5472.CAN-12-3000. Cancer Res. 2013. PMID: 23554447
MCL-1 dependency of cisplatin-resistant cancer cells.
Michels J, Obrist F, Vitale I, Lissa D, Garcia P, Behnam-Motlagh P, Kohno K, Wu GS, Brenner C, Castedo M, Kroemer G. Michels J, et al. Among authors: garcia p. Biochem Pharmacol. 2014 Nov 1;92(1):55-61. doi: 10.1016/j.bcp.2014.07.029. Epub 2014 Aug 12. Biochem Pharmacol. 2014. PMID: 25107702
Immune effectors responsible for the elimination of hyperploid cancer cells.
Aranda F, Chaba K, Bloy N, Garcia P, Bordenave C, Martins I, Stoll G, Tesniere A, Kroemer G, Senovilla L. Aranda F, et al. Among authors: garcia p. Oncoimmunology. 2018 May 21;7(8):e1463947. doi: 10.1080/2162402X.2018.1463947. eCollection 2018. Oncoimmunology. 2018. PMID: 30221060 Free PMC article.
Trial watch: DNA vaccines for cancer therapy.
Senovilla L, Vacchelli E, Garcia P, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Senovilla L, et al. Among authors: garcia p. Oncoimmunology. 2013 Apr 1;2(4):e23803. doi: 10.4161/onci.23803. Oncoimmunology. 2013. PMID: 23734328 Free PMC article.
Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention.
Lissa D, Senovilla L, Rello-Varona S, Vitale I, Michaud M, Pietrocola F, Boilève A, Obrist F, Bordenave C, Garcia P, Michels J, Jemaà M, Kepp O, Castedo M, Kroemer G. Lissa D, et al. Among authors: garcia p. Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3020-5. doi: 10.1073/pnas.1318440111. Epub 2014 Feb 10. Proc Natl Acad Sci U S A. 2014. PMID: 24516128 Free PMC article.
12 results